-
On the policy side, pharmaceutical companies need to pay close attention to changes in Pharmacopoeia, ICH, PIC/s.
-
On the production side, pharmaceutical companies need to optimize the supply chain and improve the continuous, digital, and efficient pharmaceutical process.
-
On the supply side, with the advancement of the related review and approval of the original auxiliary packaging and pharmaceutical preparations, pharmaceutical companies and original auxiliary packaging suppliers need to maintain continuous and efficient communication, and carry out product associations and changes to ensure a stable supply. The level of intensification ensures a stable supply of medicines.
-
on the product side, preparation companies need to pay attention to the research and development of innovative drugs, especially biological preparations, improved new drugs and complex preparations, and enrich their product lines through joint development or outsourcing.